Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 618 entries
Sorted by: Best Match Show Resources per page
A Conversation Between Johnese Spisso and Johannes Czernin.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Spisso J, Czernin J.
PMID: 32385168
J Nucl Med. 2020 Jun;61(6):777-779. doi: 10.2967/jnumed.120.247874. Epub 2020 May 08.

No abstract available.

Cite
Spisso J, Czernin J. A Conversation Between Johnese Spisso and Johannes Czernin. J Nucl Med. 2020;61(6):777-779doi: 10.2967/jnumed.120.247874.
Spisso, J., & Czernin, J. (2020). A Conversation Between Johnese Spisso and Johannes Czernin. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 61(6), 777-779. https://doi.org/10.2967/jnumed.120.247874
Spisso, Johnese, and Czernin, Johannes. "A Conversation Between Johnese Spisso and Johannes Czernin." Journal of nuclear medicine : official publication, Society of Nuclear Medicine vol. 61,6 (2020): 777-779. doi: https://doi.org/10.2967/jnumed.120.247874
Spisso J, Czernin J. A Conversation Between Johnese Spisso and Johannes Czernin. J Nucl Med. 2020 Jun;61(6):777-779. doi: 10.2967/jnumed.120.247874. Epub 2020 May 08. PMID: 32385168.
Copy Download .nbib Format: NLM
Ophthalmology and COVID-19.

JAMA

Bressler NM.
PMID: 32960257
JAMA. 2020 Sep 22;324(12):1143-1144. doi: 10.1001/jama.2020.17595.

No abstract available.

Cite
Bressler NM. Ophthalmology and COVID-19. JAMA. 2020;324(12):1143-1144doi: 10.1001/jama.2020.17595.
Bressler, N. M. (2020). Ophthalmology and COVID-19. JAMA, 324(12), 1143-1144. https://doi.org/10.1001/jama.2020.17595
Bressler, Neil M. "Ophthalmology and COVID-19." JAMA vol. 324,12 (2020): 1143-1144. doi: https://doi.org/10.1001/jama.2020.17595
Bressler NM. Ophthalmology and COVID-19. JAMA. 2020 Sep 22;324(12):1143-1144. doi: 10.1001/jama.2020.17595. PMID: 32960257.
Copy Download .nbib Format: NLM
Unprecedented action has been taken to contain the epidemic of coronavirus disease 2019 in China.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences

Wu T, Hu E, Zeng W, Zhang H, Xue X, Ma J.
PMID: 32386027
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 Mar 28;45(3):334-337. doi: 10.11817/j.issn.1672-7347.2020.200103.

The current outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, has posed significant threats to international health. By Feb. 20, 2020, 74 576 cases have been confirmed and over 2 118 deaths have reported in the Chinese mainland....

Cite
Wu T, Hu E, Zeng W, et al. 中国采取史无前例举措控制2019冠状病毒病流行. Unprecedented action has been taken to contain the epidemic of coronavirus disease 2019 in China. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020;45(3):334-337doi: 10.11817/j.issn.1672-7347.2020.200103.
Wu, T., Hu, E., Zeng, W., Zhang, H., Xue, X., & Ma, J. (2020). 中国采取史无前例举措控制2019冠状病毒病流行. Unprecedented action has been taken to contain the epidemic of coronavirus disease 2019 in China. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 45(3), 334-337. https://doi.org/10.11817/j.issn.1672-7347.2020.200103
Wu, Tong, et al. "中国采取史无前例举措控制2019冠状病毒病流行." Unprecedented action has been taken to contain the epidemic of coronavirus disease 2019 in China. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences vol. 45,3 (2020): 334-337. doi: https://doi.org/10.11817/j.issn.1672-7347.2020.200103
Wu T, Hu E, Zeng W, Zhang H, Xue X, Ma J. 中国采取史无前例举措控制2019冠状病毒病流行. Unprecedented action has been taken to contain the epidemic of coronavirus disease 2019 in China. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 Mar 28;45(3):334-337. doi: 10.11817/j.issn.1672-7347.2020.200103. Chinese. PMID: 32386027.
Copy Download .nbib Format: NLM
Viewpoint: The COVID-19 and climate crises.

The British journal of general practice : the journal of the Royal College of General Practitioners

Morrison L.
PMID: 32354815
Br J Gen Pract. 2020 Apr 30;70(694):241. doi: 10.3399/bjgp20X709637. Print 2020 May.

No abstract available.

Cite
Morrison L. Viewpoint: The COVID-19 and climate crises. Br J Gen Pract. 2020;70(694):241doi: 10.3399/bjgp20X709637.
Morrison, L. (2020). Viewpoint: The COVID-19 and climate crises. The British journal of general practice : the journal of the Royal College of General Practitioners, 70(694), 241. https://doi.org/10.3399/bjgp20X709637
Morrison, Lesley. "Viewpoint: The COVID-19 and climate crises." The British journal of general practice : the journal of the Royal College of General Practitioners vol. 70,694 (2020): 241. doi: https://doi.org/10.3399/bjgp20X709637
Morrison L. Viewpoint: The COVID-19 and climate crises. Br J Gen Pract. 2020 Apr 30;70(694):241. doi: 10.3399/bjgp20X709637. Print 2020 May. PMID: 32354815; PMCID: PMC7194752.
Copy Download .nbib Format: NLM
Obesity and impaired metabolic health in patients with COVID-19.

Nature reviews. Endocrinology

Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS.
PMID: 32327737
Nat Rev Endocrinol. 2020 Jul;16(7):341-342. doi: 10.1038/s41574-020-0364-6.

No abstract available.

Cite
Stefan N, Birkenfeld AL, Schulze MB, et al. Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol. 2020;16(7):341-342doi: 10.1038/s41574-020-0364-6.
Stefan, N., Birkenfeld, A. L., Schulze, M. B., & Ludwig, D. S. (2020). Obesity and impaired metabolic health in patients with COVID-19. Nature reviews. Endocrinology, 16(7), 341-342. https://doi.org/10.1038/s41574-020-0364-6
Stefan, Norbert, et al. "Obesity and impaired metabolic health in patients with COVID-19." Nature reviews. Endocrinology vol. 16,7 (2020): 341-342. doi: https://doi.org/10.1038/s41574-020-0364-6
Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS. Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol. 2020 Jul;16(7):341-342. doi: 10.1038/s41574-020-0364-6. PMID: 32327737; PMCID: PMC7187148.
Copy Download .nbib Format: NLM
This is real.

Science (New York, N.Y.)

Thorp HH.
PMID: 32220830
Science. 2020 Apr 03;368(6486):7. doi: 10.1126/science.abb9223. Epub 2020 Mar 27.

No abstract available.

Cite
Thorp HH. This is real. Science. 2020;368(6486):7doi: 10.1126/science.abb9223.
Thorp, H. H. (2020). This is real. Science (New York, N.Y.), 368(6486), 7. https://doi.org/10.1126/science.abb9223
Thorp, H Holden. "This is real." Science (New York, N.Y.) vol. 368,6486 (2020): 7. doi: https://doi.org/10.1126/science.abb9223
Thorp HH. This is real. Science. 2020 Apr 03;368(6486):7. doi: 10.1126/science.abb9223. Epub 2020 Mar 27. PMID: 32220830.
Copy Download .nbib Format: NLM
Testing for COVID-19 in lung cancer patients.

Annals of oncology : official journal of the European Society for Medical Oncology

Passaro A, Peters S, Mok TSK, Attili I, Mitsudomi T, de Marinis F.
PMID: 32278879
Ann Oncol. 2020 Jul;31(7):832-834. doi: 10.1016/j.annonc.2020.04.002. Epub 2020 Apr 09.

No abstract available.

Cite
Passaro A, Peters S, Mok TSK, et al. Testing for COVID-19 in lung cancer patients. Ann Oncol. 2020;31(7):832-834doi: 10.1016/j.annonc.2020.04.002.
Passaro, A., Peters, S., Mok, T. S. K., Attili, I., Mitsudomi, T., & de Marinis, F. (2020). Testing for COVID-19 in lung cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology, 31(7), 832-834. https://doi.org/10.1016/j.annonc.2020.04.002
Passaro, A, et al. "Testing for COVID-19 in lung cancer patients." Annals of oncology : official journal of the European Society for Medical Oncology vol. 31,7 (2020): 832-834. doi: https://doi.org/10.1016/j.annonc.2020.04.002
Passaro A, Peters S, Mok TSK, Attili I, Mitsudomi T, de Marinis F. Testing for COVID-19 in lung cancer patients. Ann Oncol. 2020 Jul;31(7):832-834. doi: 10.1016/j.annonc.2020.04.002. Epub 2020 Apr 09. PMID: 32278879; PMCID: PMC7144604.
Copy Download .nbib Format: NLM
Tackling two pandemics: a plea on World Tuberculosis Day.

The Lancet. Respiratory medicine

Wingfield T, Cuevas LE, MacPherson P, Millington KA, Squire SB.
PMID: 32220280
Lancet Respir Med. 2020 Jun;8(6):536-538. doi: 10.1016/S2213-2600(20)30151-X. Epub 2020 Mar 24.

No abstract available.

Cite
Wingfield T, Cuevas LE, MacPherson P, et al. Tackling two pandemics: a plea on World Tuberculosis Day. Lancet Respir Med. 2020;8(6):536-538doi: 10.1016/S2213-2600(20)30151-X.
Wingfield, T., Cuevas, L. E., MacPherson, P., Millington, K. A., & Squire, S. B. (2020). Tackling two pandemics: a plea on World Tuberculosis Day. The Lancet. Respiratory medicine, 8(6), 536-538. https://doi.org/10.1016/S2213-2600(20)30151-X
Wingfield, Tom, et al. "Tackling two pandemics: a plea on World Tuberculosis Day." The Lancet. Respiratory medicine vol. 8,6 (2020): 536-538. doi: https://doi.org/10.1016/S2213-2600(20)30151-X
Wingfield T, Cuevas LE, MacPherson P, Millington KA, Squire SB. Tackling two pandemics: a plea on World Tuberculosis Day. Lancet Respir Med. 2020 Jun;8(6):536-538. doi: 10.1016/S2213-2600(20)30151-X. Epub 2020 Mar 24. PMID: 32220280; PMCID: PMC7118542.
Copy Download .nbib Format: NLM
Beware of the second wave of COVID-19.

Lancet (London, England)

Xu S, Li Y.
PMID: 32277876
Lancet. 2020 Apr 25;395(10233):1321-1322. doi: 10.1016/S0140-6736(20)30845-X. Epub 2020 Apr 08.

No abstract available.

Cite
Xu S, Li Y. Beware of the second wave of COVID-19. Lancet. 2020;395(10233):1321-1322doi: 10.1016/S0140-6736(20)30845-X.
Xu, S., & Li, Y. (2020). Beware of the second wave of COVID-19. Lancet (London, England), 395(10233), 1321-1322. https://doi.org/10.1016/S0140-6736(20)30845-X
Xu, Shunqing, and Li, Yuanyuan. "Beware of the second wave of COVID-19." Lancet (London, England) vol. 395,10233 (2020): 1321-1322. doi: https://doi.org/10.1016/S0140-6736(20)30845-X
Xu S, Li Y. Beware of the second wave of COVID-19. Lancet. 2020 Apr 25;395(10233):1321-1322. doi: 10.1016/S0140-6736(20)30845-X. Epub 2020 Apr 08. PMID: 32277876; PMCID: PMC7194658.
Copy Download .nbib Format: NLM
Good leadership will see vets through.

The Veterinary record

Waters A.
PMID: 32220984
Vet Rec. 2020 Mar 28;186(12):363. doi: 10.1136/vr.m1229.

No abstract available.

Cite
Waters A. Good leadership will see vets through. Vet Rec. 2020;186(12):363doi: 10.1136/vr.m1229.
Waters, A. (2020). Good leadership will see vets through. The Veterinary record, 186(12), 363. https://doi.org/10.1136/vr.m1229
Waters, Adele. "Good leadership will see vets through." The Veterinary record vol. 186,12 (2020): 363. doi: https://doi.org/10.1136/vr.m1229
Waters A. Good leadership will see vets through. Vet Rec. 2020 Mar 28;186(12):363. doi: 10.1136/vr.m1229. PMID: 32220984.
Copy Download .nbib Format: NLM
Building relevance to improve public adherence to preventive measures against COVID-19 by reporting prevalence assessment from incidence numbers.

Danish medical journal

Lorentzen HF, Vestergaard C, Benfield T.
PMID: 32800074
Dan Med J. 2020 Aug 14;67(9).

No abstract available.

Cite
Lorentzen HF, Vestergaard C, Benfield T. Building relevance to improve public adherence to preventive measures against COVID-19 by reporting prevalence assessment from incidence numbers. Dan Med J. 2020;67(9)
Lorentzen, H. F., Vestergaard, C., & Benfield, T. (2020). Building relevance to improve public adherence to preventive measures against COVID-19 by reporting prevalence assessment from incidence numbers. Danish medical journal, 67(9), .
Lorentzen, Henrik F, et al. "Building relevance to improve public adherence to preventive measures against COVID-19 by reporting prevalence assessment from incidence numbers." Danish medical journal vol. 67,9 (2020).
Lorentzen HF, Vestergaard C, Benfield T. Building relevance to improve public adherence to preventive measures against COVID-19 by reporting prevalence assessment from incidence numbers. Dan Med J. 2020 Aug 14;67(9). PMID: 32800074.
Copy Download .nbib Format: NLM
Predictions for the COVID-19 pandemic in Germany using the modified Bateman SIZ model.

International journal of clinical pharmacology and therapeutics

Braun P, Haffner S, Aguirre Davila L, Braun J, Woodcock BG.
PMID: 32800093
Int J Clin Pharmacol Ther. 2020 Sep;58(9):467-474. doi: 10.5414/CP203868.

AIMS OF THE STUDY: To obtain predictions for the course of the COVID-19 pandemic in Germany using the modified Bateman SIZ model and input variables based on the status quo in July 2020. To predict the effect of a...

Cite
Braun P, Haffner S, Aguirre Davila L, et al. Predictions for the COVID-19 pandemic in Germany using the modified Bateman SIZ model. Int J Clin Pharmacol Ther. 2020;58(9):467-474doi: 10.5414/CP203868.
Braun, P., Haffner, S., Aguirre Davila, L., Braun, J., & Woodcock, B. G. (2020). Predictions for the COVID-19 pandemic in Germany using the modified Bateman SIZ model. International journal of clinical pharmacology and therapeutics, 58(9), 467-474. https://doi.org/10.5414/CP203868
Braun, Peter, et al. "Predictions for the COVID-19 pandemic in Germany using the modified Bateman SIZ model." International journal of clinical pharmacology and therapeutics vol. 58,9 (2020): 467-474. doi: https://doi.org/10.5414/CP203868
Braun P, Haffner S, Aguirre Davila L, Braun J, Woodcock BG. Predictions for the COVID-19 pandemic in Germany using the modified Bateman SIZ model. Int J Clin Pharmacol Ther. 2020 Sep;58(9):467-474. doi: 10.5414/CP203868. PMID: 32800093.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 618 entries